Atlas Trials

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

Clinical trial NCT03051243 · UNKNOWN

Trial details

NCT number
NCT03051243
Sponsor
Rabin Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
DM2
Start date
2017-10-01
Primary completion
2018-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.